BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 10844079)

  • 21. Radiation optic neuropathy after proton beam therapy for optic nerve sheath meningioma.
    Siddiqui JD; Loeffler JS; Murphy MA
    J Neuroophthalmol; 2013 Jun; 33(2):165-8. PubMed ID: 23429064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preservation of residual vision 2 years after stereotactic radiosurgery for a presumed optic nerve sheath meningioma.
    Klink DF; Miller NR; Williams J
    J Neuroophthalmol; 1998 Jun; 18(2):117-20. PubMed ID: 9621268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A long-term visual outcome comparison in patients with optic nerve sheath meningioma managed with observation, surgery, radiotherapy, or surgery and radiotherapy.
    Turbin RE; Thompson CR; Kennerdell JS; Cockerham KP; Kupersmith MJ
    Ophthalmology; 2002 May; 109(5):890-9; discussion 899-900. PubMed ID: 11986093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Big muscles and big nerves.
    Dabbs CB; Kline LB
    Surv Ophthalmol; 1997; 42(3):247-54. PubMed ID: 9406370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiotherapy for optic nerve sheath meningioma: a case for earlier intervention?
    Adams G; Roos DE; Crompton JL
    Clin Oncol (R Coll Radiol); 2013 Jun; 25(6):356-61. PubMed ID: 23489873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fractionated stereotactic radiotherapy for the treatment of optic nerve sheath meningiomas: preliminary observations of 33 optic nerves in 30 patients with historical comparison to observation with or without prior surgery.
    Andrews DW; Faroozan R; Yang BP; Hudes RS; Werner-Wasik M; Kim SM; Sergott RC; Savino PJ; Shields J; Shields C; Downes MB; Simeone FA; Goldman HW; Curran WJ
    Neurosurgery; 2002 Oct; 51(4):890-902; discussion 903-4. PubMed ID: 12234395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary radiotherapy for optic nerve sheath meningioma.
    Melian E; Jay WM
    Semin Ophthalmol; 2004; 19(3-4):130-40. PubMed ID: 15590556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involution of retinochoroidal shunt vessel after radiotherapy for optic nerve sheath meningioma.
    Mashayekhi A; Shields JA; Shields CL
    Eur J Ophthalmol; 2004; 14(1):61-4. PubMed ID: 15005588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immediate shrinkage of optociliary shunt vessels after fractionated external beam radiation for meningioma of the optic nerve sheath.
    de Alba Campomanes AG; Larson DA; Horton JC
    AJNR Am J Neuroradiol; 2008 Aug; 29(7):1360-2. PubMed ID: 18403557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retrospective analysis of fractionated intensity-modulated radiotherapy (IMRT) in the interdisciplinary management of primary optic nerve sheath meningiomas.
    Eckert F; Clasen K; Kelbsch C; Tonagel F; Bender B; Tabatabai G; Zips D; Thorwarth D; Frey B; Becker G; Wilhelm H; Paulsen F
    Radiat Oncol; 2019 Dec; 14(1):240. PubMed ID: 31881902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereotactic fractionated irradiation of optic nerve sheath meningioma: a new treatment alternative.
    Pitz S; Becker G; Schiefer U; Wilhelm H; Jeremic B; Bamberg M; Zrenner E
    Br J Ophthalmol; 2002 Nov; 86(11):1265-8. PubMed ID: 12386086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Results of radiation therapy for optic nerve sheath meningioma].
    Sergeeva NA; Serova NK; Galkin MV; Golanov AV; Zagirov RI
    Vestn Oftalmol; 2022; 138(5):5-13. PubMed ID: 36288412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Optic nerve sheath meningeoma--from expectation to active treatment].
    Kerty E
    Tidsskr Nor Laegeforen; 2005 Feb; 125(4):429-30. PubMed ID: 15742013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early intervention using high-precision radiotherapy preserved visual function for five consecutive patients with optic nerve sheath meningioma.
    Inoue T; Mimura O; Masai N; Ohashi A; Ikenaga K; Okuno Y; Nishiguchi I; Oh R
    Int J Clin Oncol; 2018 Oct; 23(5):826-834. PubMed ID: 29713911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Reversible unilateral blindness].
    Naxer S; Hille A; Wolff HA; Schittkowski MP
    Klin Monbl Augenheilkd; 2012 Oct; 229(10):1018-20. PubMed ID: 23011606
    [No Abstract]   [Full Text] [Related]  

  • 36. Optic nerve sheath meningiomas and advanced treatment options.
    Carrasco JR; Penne RB
    Curr Opin Ophthalmol; 2004 Oct; 15(5):406-10. PubMed ID: 15625901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of sight-threatening optic nerve sheath meningioma with fractionated stereotactic radiotherapy.
    Richards JC; Roden D; Harper CS
    Clin Exp Ophthalmol; 2005 Apr; 33(2):137-41. PubMed ID: 15807820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term treatment outcomes of patients with primary optic nerve sheath meningioma treated with stereotactic radiotherapy.
    Ratnayake G; Oh T; Mehta R; Hardy T; Woodford K; Haward R; Ruben JD; Dally MJ
    J Clin Neurosci; 2019 Oct; 68():162-167. PubMed ID: 31401001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiation therapy for primary optic nerve meningiomas.
    Smith JL; Vuksanovic MM; Yates BM; Bienfang DC
    J Clin Neuroophthalmol; 1981 Jun; 1(2):85-99. PubMed ID: 6213657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary optic nerve sheath meningioma: stereotactic fractionated radiation therapy as an emerging treatment of choice.
    Jeremic B; Pitz S
    Cancer; 2007 Aug; 110(4):714-22. PubMed ID: 17582618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.